Pursuant to the provisions of Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), Trident Texofab has informed about the statement of deviation or variation in public issue, rights issue, preferential issue etc. for the half year ended on 31st March, 2018.
The above information is a part of company’s filings submitted to BSE.